Gritstone bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2017 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Gritstone bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2017 to Q2 2024.
Gritstone bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.47M, a 17.9% increase year-over-year.
Gritstone bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $12.5M, a 5.02% increase year-over-year.
Gritstone bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $11.6M, a 7.48% decline from 2022.
Gritstone bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12.6M, a 19% increase from 2021.
Gritstone bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.6M, a 48.4% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$12.5M	$3.47M	+$527K	+17.9%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$12M	$3.25M	+$355K	+12.3%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$11.6M	$2.82M	-$185K	-6.15%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-05
Q3 2023	$11.8M	$2.96M	-$100K	-3.26%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$11.9M	$2.94M	-$414K	-12.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-13
Q1 2023	$12.3M	$2.89M	-$240K	-7.67%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$12.6M	$3.01M	+$209K	+7.47%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-05
Q3 2022	$12.3M	$3.06M	+$245K	+8.69%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	$12.1M	$3.35M	+$621K	+22.7%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	$11.5M	$3.13M	+$930K	+42.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$10.6M	$2.8M	+$1.1M	+64.9%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-05
Q3 2021	$9.45M	$2.82M	+$982K	+53.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$8.47M	$2.73M	+$776K	+39.7%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$7.69M	$2.2M	+$582K	+35.9%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$7.11M	$1.7M	+$254K	+17.6%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-09
Q3 2020	$6.86M	$1.84M	+$305K	+19.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-03
Q2 2020	$6.55M	$1.96M	+$640K	+48.6%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$5.91M	$1.62M	+$612K	+60.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$5.3M	$1.44M	+$160K	+12.5%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-10
Q3 2019	$5.14M	$1.53M	+$993K	+184%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$4.15M	$1.32M	+$498K	+60.8%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-05
Q1 2019	$3.65M	$1.01M	+$653K	+184%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$3M	$1.28M			Oct 1, 2018	Dec 31, 2018	10-K	2021-03-11
Q3 2018		$539K	+$234K	+76.7%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018		$819K			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-12
Q1 2018		$354K			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-13
Q3 2017		$305K			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.